Repertoire Immune Medicines United States of America (USA)

Research

Date range: 1 December 2020 - 30 November 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Repertoire Immune Medicines published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Repertoire Immune Medicines
Count Share
3 0.34

Outputs by subject (Share)

Outputs by subject
Subject Count Share
2 0.24
1 0.10

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 0.09

Compare Repertoire Immune Medicines with other institutions

Collaboration

Date range: 1 December 2020 - 30 November 2021

International vs. domestic collaboration by Share

  • 79.63% Domestic
  • 20.37% International

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with Repertoire Immune Medicines by Share (20 total)

  1. Repertoire Immune Medicines and Bristol-Myers Squibb (BMS) (1.00)
    Repertoire Immune Medicines0.10
    Bristol-Myers Squibb (BMS)0.90
  2. Repertoire Immune Medicines and Harvard University (0.85)
    Repertoire Immune Medicines0.24
    Harvard University0.61
  3. Repertoire Immune Medicines and Broad Institute of MIT and Harvard (0.45)
    Repertoire Immune Medicines0.15
    Broad Institute of MIT and Harvard0.31
  4. Repertoire Immune Medicines and The University of Utah (Utah) (0.42)
    Repertoire Immune Medicines0.09
    The University of Utah (Utah)0.33
  5. Repertoire Immune Medicines and Massachusetts Institute of Technology (MIT) (0.31)
    Repertoire Immune Medicines0.15
    Massachusetts Institute of Technology (MIT)0.16
  6. Repertoire Immune Medicines and Boston University (BU) (0.23)
    Repertoire Immune Medicines0.15
    Boston University (BU)0.08
  7. Repertoire Immune Medicines and Mount Sinai Health System (MSHS) (0.20)
    Repertoire Immune Medicines0.15
    Mount Sinai Health System (MSHS)0.05
  8. Repertoire Immune Medicines and La Jolla Institute for Immunology (LJI) (0.18)
    Repertoire Immune Medicines0.15
    La Jolla Institute for Immunology (LJI)0.04
  9. Repertoire Immune Medicines and University of Pennsylvania (Penn) (0.18)
    Repertoire Immune Medicines0.09
    University of Pennsylvania (Penn)0.09
  10. Repertoire Immune Medicines and The Rockefeller University (0.17)
    Repertoire Immune Medicines0.15
    The Rockefeller University0.02

Top 10 international collaborators with Repertoire Immune Medicines by Share (8 total)

  1. Repertoire Immune Medicines and McGill University (0.27)
    Repertoire Immune Medicines0.09
    McGill University0.18
  2. Repertoire Immune Medicines and Northwest A&F University (NWAFU) (0.21)
    Repertoire Immune Medicines0.09
    Northwest A&F University (NWAFU)0.12
  3. Repertoire Immune Medicines and Weizmann Institute of Science (WIS) (0.20)
    Repertoire Immune Medicines0.15
    Weizmann Institute of Science (WIS)0.05
  4. Repertoire Immune Medicines and Guangzhou Medical University (GMU) (0.15)
    Repertoire Immune Medicines0.15
    Guangzhou Medical University (GMU)0.00
  5. Repertoire Immune Medicines and Charité - University Medicine Berlin (0.15)
    Repertoire Immune Medicines0.15
    Charité - University Medicine Berlin0.00
  6. Repertoire Immune Medicines and University of Zurich (UZH) (0.15)
    Repertoire Immune Medicines0.15
    University of Zurich (UZH)0.00
  7. Repertoire Immune Medicines and Free University of Berlin (FU Berlin) (0.15)
    Repertoire Immune Medicines0.15
    Free University of Berlin (FU Berlin)0.00
  8. Repertoire Immune Medicines and Humboldt University of Berlin (HU Berlin) (0.15)
    Repertoire Immune Medicines0.15
    Humboldt University of Berlin (HU Berlin)0.00

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.